Clinical Trial Update: Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19 [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing two dexamethasone doses in patients with ARDS and COVID-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Brno University Hospital | Conditions: Covid19, ARDS | Phase 4 | Status: COMPLETED